Is early, deep free light chain response really an adverse prognostic factor?

被引:6
作者
Dispenzieri, Angela [1 ]
机构
[1] Mayo Clin, Rochester, MN 55905 USA
关键词
D O I
10.1182/blood-2007-11-125849
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:2490 / 2491
页数:2
相关论文
共 1 条
[1]
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis [J].
van Rhee, Frits ;
Bolejack, Vanessa ;
Hollmig, Klaus ;
Pineda-Roman, Mauricio ;
Anaissie, Elias ;
Epstein, Joshua ;
Shaughnessy, John D., Jr. ;
Zangari, Maurizio ;
Tricot, Guido ;
Mohiuddin, Abid ;
Alsayed, Yazan ;
Woods, Gail ;
Crowley, John ;
Barlogie, Bart .
BLOOD, 2007, 110 (03) :827-832